×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

InsideArbitrage Event Driven Monitor – January 5, 2023

  • January 5, 2023
Quick updates on the event-driven strategies we follow on InsideArbitrage. Merger Arbitrage Orthofix (OFIX) completed the acquisition of SeaSpine Holdings Corporation (SPNE). Opiant Pharmaceuticals (OPNT) announced that the special meeting of stockholders will be on March 1, 2023. The waiting period under the HSR Act was initially scheduled to expire on January 3, 2023. On December 30, 2022 and January 3, 2023, Indivior withdrew and refiled its HSR Notification. The renewed HSR waiting period will expire on February 2, 2023. The companies filed a voluntary CFIUS Notice seeking approval of the Merger on December 19, 2022. The CFIUS review period is expected to conclude no later than February 6, 2023. Maverix Metals (MMX) announced that independent proxy advisory firms, Institutional Shareholder Services and Glass Lewis have recommended that Maverix shareholders vote in favor of the arrangement with Triple Flag Precious Metals (TFPM). Deals In The Works The board of directors of Sesen Bio (SESN) reiterates its desire to merge with Carisma Therapeutics. According to Bloomberg, Western Digital Corp.Western Digital (WDC) has restarted talks with Japan’s Kioxia Holdings Corp. in a deal that could unite two technology storage providers. According to Bloomberg, Payments-software provider ACI Worldwide (ACIW) is in talks with private equity firms about a...

Only plus or premium subscribers can access this post. Subscribe today.